How should incidental NEN of the pancreas and gastrointestinal tract be followed?

R Ariotti, S Partelli, F Muffatti, V Andreasi, F della Sala, M Falconi

Research output: Contribution to journalArticle

Abstract

Neuroendocrine gastro-entero-pancreatic neoplasms (GEP-NENs) constitute a heterogeneous group of tumors, whose incidence has increased over the years. The most frequent site for primary disease is the stomach followed by small and large intestine, and pancreas. In the last decade, a dramatic growing in the incidence of small, incidental GEP-NENs has been recorded. In parallel, an increasing attitude toward more conservative approaches instead of surgical management has being widely spreading. This is particularly true for small, asymptomatic, pancreatic NEN as for these tumor forms an active surveillance has proven to be safe and feasible. Primary site and biological features of the neoplasms lead to different strategies and indications for surveillance and follow-up. This review focuses on the current evidence on modality and timing of surveillance and conservative treatment of incidentally discovered lesions. © 2018 Springer Science+Business Media, LLC, part of Springer Nature
Original languageEnglish
Pages (from-to)139-144
Number of pages6
JournalReviews in Endocrine and Metabolic Disorders
Volume19
Issue number2
DOIs
Publication statusPublished - 2018

Fingerprint

Gastrointestinal Tract
Pancreas
Stomach Diseases
Neoplasms
Large Intestine
Incidence
Pancreatic Neoplasms
Small Intestine
Conservative Treatment

Cite this

How should incidental NEN of the pancreas and gastrointestinal tract be followed? / Ariotti, R; Partelli, S; Muffatti, F; Andreasi, V; della Sala, F; Falconi, M.

In: Reviews in Endocrine and Metabolic Disorders, Vol. 19, No. 2, 2018, p. 139-144.

Research output: Contribution to journalArticle

@article{d11c26fc3794491d9eafc777f2f581f2,
title = "How should incidental NEN of the pancreas and gastrointestinal tract be followed?",
abstract = "Neuroendocrine gastro-entero-pancreatic neoplasms (GEP-NENs) constitute a heterogeneous group of tumors, whose incidence has increased over the years. The most frequent site for primary disease is the stomach followed by small and large intestine, and pancreas. In the last decade, a dramatic growing in the incidence of small, incidental GEP-NENs has been recorded. In parallel, an increasing attitude toward more conservative approaches instead of surgical management has being widely spreading. This is particularly true for small, asymptomatic, pancreatic NEN as for these tumor forms an active surveillance has proven to be safe and feasible. Primary site and biological features of the neoplasms lead to different strategies and indications for surveillance and follow-up. This review focuses on the current evidence on modality and timing of surveillance and conservative treatment of incidentally discovered lesions. {\circledC} 2018 Springer Science+Business Media, LLC, part of Springer Nature",
author = "R Ariotti and S Partelli and F Muffatti and V Andreasi and {della Sala}, F and M Falconi",
year = "2018",
doi = "10.1007/s11154-018-9445-4",
language = "English",
volume = "19",
pages = "139--144",
journal = "Reviews in Endocrine and Metabolic Disorders",
issn = "1389-9155",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - How should incidental NEN of the pancreas and gastrointestinal tract be followed?

AU - Ariotti, R

AU - Partelli, S

AU - Muffatti, F

AU - Andreasi, V

AU - della Sala, F

AU - Falconi, M

PY - 2018

Y1 - 2018

N2 - Neuroendocrine gastro-entero-pancreatic neoplasms (GEP-NENs) constitute a heterogeneous group of tumors, whose incidence has increased over the years. The most frequent site for primary disease is the stomach followed by small and large intestine, and pancreas. In the last decade, a dramatic growing in the incidence of small, incidental GEP-NENs has been recorded. In parallel, an increasing attitude toward more conservative approaches instead of surgical management has being widely spreading. This is particularly true for small, asymptomatic, pancreatic NEN as for these tumor forms an active surveillance has proven to be safe and feasible. Primary site and biological features of the neoplasms lead to different strategies and indications for surveillance and follow-up. This review focuses on the current evidence on modality and timing of surveillance and conservative treatment of incidentally discovered lesions. © 2018 Springer Science+Business Media, LLC, part of Springer Nature

AB - Neuroendocrine gastro-entero-pancreatic neoplasms (GEP-NENs) constitute a heterogeneous group of tumors, whose incidence has increased over the years. The most frequent site for primary disease is the stomach followed by small and large intestine, and pancreas. In the last decade, a dramatic growing in the incidence of small, incidental GEP-NENs has been recorded. In parallel, an increasing attitude toward more conservative approaches instead of surgical management has being widely spreading. This is particularly true for small, asymptomatic, pancreatic NEN as for these tumor forms an active surveillance has proven to be safe and feasible. Primary site and biological features of the neoplasms lead to different strategies and indications for surveillance and follow-up. This review focuses on the current evidence on modality and timing of surveillance and conservative treatment of incidentally discovered lesions. © 2018 Springer Science+Business Media, LLC, part of Springer Nature

U2 - 10.1007/s11154-018-9445-4

DO - 10.1007/s11154-018-9445-4

M3 - Article

VL - 19

SP - 139

EP - 144

JO - Reviews in Endocrine and Metabolic Disorders

JF - Reviews in Endocrine and Metabolic Disorders

SN - 1389-9155

IS - 2

ER -